Plain-English translation of NCT05426720 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking men with tuberculosis to understand why some people develop lasting lung damage after their treatment ends. Researchers will collect information about your symptoms, lung function, and chest imaging over three years, along with blood samples to look for biological markers that might predict who is at risk. The goal is to help doctors identify patients early and prevent long-term complications.
Even after tuberculosis is cured with medication, some patients continue to have breathing problems and lung damage. This study exists to figure out which patients are most likely to experience these lasting problems and what warning signs doctors should look for, so treatment and monitoring can be improved.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital at baseline (when starting TB treatment), then return for check-ups 6 months after starting treatment, at the end of treatment, and then at 1, 2, and 3 years after finishing treatment. At each visit, you'll complete breathing tests, chest imaging scans, and answer questions about your symptoms. You'll also have one blood draw at the beginning to measure inflammation markers that might predict risk.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Collaborators
Beijing Geriatric Hospital
Enrollment target
~400 participants
Started
January 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
25 Years – 60 Years
Sex
Male only
Last updated on clinicaltrials.gov in June 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xiaoyan Gai, MD
Respiratory and Critical Care Department, Peking University Third Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.